Piramal Sees $1.5 Billion Revenue from Potential Alzheimer's Drug

16.04.2012 - Indian drugmaker Piramal Healthcare sees revenue potential of $1.5 billion from its new florbetaben molecule, a possible Alzheimer's treatment acquired by the company in a deal...